Company intelligence / Profile preview

Myocene

Liège, Wallonia, Belgium

Ownership: Private
Employees: ~8
Development stage: Other

Overview

Myocene has validated its muscle fatigue measurement device in collaboration with leading sports physiologists and universities. The device has been tested in over 1,800 athletes and is used by elite sports clubs for accurate, objective, and quantifiable muscle fatigue assessment; it recently gained FDA De Novo clearance for US deployment[2][3][1].

Therapeutic areas: OtherNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

OGC Nice (French Ligue 1 football club)RC Strasbourg (football club)Sporting Clube de Braga (football club)Saint-Raphaël Var Handball (handball club)US Ivry (handball club)Various European research/training centers (e.g. CEP Cometti, BeScored Institute)

Beyond the preview

Go deeper on Myocene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocene.

Explore the full profile